Source pharmaceutical use piroxicam for pain relief inflammation and fever

Strategic Sourcing Guide for Pharmaceutical Piroxicam Procurement

Understanding the Core Product Profile and Technical Specifications

Procuring Piroxicam for pharmaceutical applications requires a precise understanding of its chemical identity and physical properties, as these factors directly influence formulation stability and regulatory compliance. Based on available market data, Piroxicam is characterized by a specific molecular structure with the formula C15H13N3O4S and a molecular weight ranging between 331.346 and 331.35 Daltons. The substance is fundamentally a solid material, typically presenting as a white powder in its raw form, though it is also processed into tablets for final administration. The primary chemical identifier, CAS number 2022-85-7, serves as the critical reference point for verifying the authenticity of the material during the sourcing process.

The physical state of the raw material is predominantly observed as a powder, which necessitates specific handling protocols to maintain integrity before compounding. While the raw material is a powder, the end-application often targets oral administration for internal medicine, specifically for its anti-inflammatory function. This dual nature—raw powder for manufacturing and final tablet form for patients—requires buyers to clarify whether they are sourcing the active pharmaceutical ingredient (API) or finished dosage forms. The standard purity for the raw material is frequently cited as exceeding 99%, with specific product standards often requiring a minimum of 99% Piroxicam content. Buyers must verify that the "99%" figure refers to the assay of the active ingredient and not merely the overall content, as this distinction impacts the efficacy of the final drug product.

Regulatory Compliance and Certification Verification

In the pharmaceutical sector, certification is not merely a formality but a prerequisite for market access and patient safety. When sourcing Piroxicam, buyers must rigorously audit suppliers for adherence to recognized international and regional quality standards. The supply chain data indicates that compliant products often carry certifications such as USP (United States Pharmacopeia), BP (British Pharmacopeia), and ISO GMP (Good Manufacturing Practice). Additionally, some listings reference ISO HSE standards, which pertain to health, safety, and environmental management, indicating a supplier's commitment to operational safety alongside product quality.

The verification process should extend beyond the mere presence of a certificate. Buyers need to confirm that the certification covers the specific manufacturing site and the specific batch of Piroxicam being procured. The presence of a USP or BP certification implies that the material meets the rigorous monograph requirements for identity, strength, quality, and purity. For suppliers claiming "Pharmaceutical Grade" status, the documentation must align with these pharmacopeial standards. It is also critical to note that while some product profiles list "Natural" as a resource attribute, Piroxicam is chemically synthesized via pharmaceutical technology. Therefore, buyers should be cautious of conflicting claims and ensure that the "Natural" designation does not mislead regarding the synthesis method, which is explicitly noted as chemical synthesis in technical specifications.

Cost Drivers and Minimum Order Quantity Dynamics

The economics of sourcing Piroxicam are influenced by a complex interplay of order volume, packaging requirements, and supply chain logistics. The observed Minimum Order Quantity (MOQ) in the market is highly variable, ranging from small quantities of 100 grams or 1 kilogram to substantial bulk orders of up to 10,000,000 units. This wide range suggests that the market accommodates both small-scale research and development needs and large-scale commercial manufacturing. For a procurement strategy focused on cost efficiency, understanding the tiered pricing structure associated with these MOQs is essential. While specific price points are not fixed in the provided data, the observed price range in the market spans from $0 to $130 USD, likely reflecting differences in purity, packaging, and order volume.

Packaging plays a significant role in cost and logistics. The standard packaging for Piroxicam powder includes 1kg foil bags, which are often bundled into cartons (e.g., 10 bags per carton) or placed into 25kg drums for larger shipments. The choice between foil bags and drums impacts the unit cost and the handling requirements at the destination. Foil bags are ideal for smaller batches or where moisture protection is critical in a controlled environment, while drums offer a more economical solution for bulk storage and transport. Buyers should evaluate whether the "1kg Foil Bag / 25kg Drum" specification aligns with their storage capacity and inventory turnover rates. Additionally, the "Customization" attribute indicates that suppliers may offer tailored packaging solutions, which could affect the final cost and lead time.

Typical Applications and Formulation Considerations

Piroxicam is primarily utilized in the field of internal medicine as an anti-inflammatory agent. Its application is designed for oral administration, making it a key ingredient in formulations intended for the treatment of conditions requiring pain relief and inflammation reduction. The target demographic for products containing Piroxicam includes adults, children, and the elderly, although the specific dosage and formulation must be carefully calibrated for each group. The product is classified under biological products in some contexts, though its synthesis is chemical, highlighting the complexity of its classification in regulatory frameworks.

When formulating Piroxicam into final dosage forms, the "Shape" attribute indicates that tablets are a common end-product. The transition from raw white powder to a stable tablet requires precise pharmaceutical technology and quality control measures. The "Usage Mode" being oral administration dictates that the excipients and binding agents used in the tablet formulation must be compatible with Piroxicam's chemical properties. Furthermore, the "Application" as internal medicine implies that the product must meet stringent bioavailability and dissolution standards. Buyers sourcing the raw material for formulation should ensure that the supplier provides data on the particle size and flow properties of the powder, as these physical characteristics are critical for tablet compression and uniformity.

Supplier Evaluation and Quality Control Protocols

Selecting a reliable supplier for Piroxicam involves a multi-faceted evaluation process that goes beyond price comparison. The origin of the product is a significant factor, with China, specifically the Shaanxi region, identified as a key production hub. While the location is noted, buyers must verify the specific manufacturing capabilities of the facility in Shaanxi or other reported origins. The "Quality Requirement" of "Strictly Quality Control" is a common claim, but it must be substantiated by documented procedures.

Quality control protocols should include the use of validated test methods. High-performance liquid chromatography (HPLC) is the specified test method for verifying the purity and identity of Piroxicam. Buyers should request recent test reports generated using HPLC to ensure the material meets the stated purity of >99%. The "Test Method" must be consistent with pharmacopeial standards. Additionally, the "Storage" requirements are critical; the product must be stored in a cool, dry place to maintain stability. The "Shelf Life" is typically cited as 2 years under proper storage conditions, but this is contingent on the integrity of the packaging and the environmental conditions during transit and storage.

Long-Term Procurement and Supply Chain Stability

Sourcing Piroxicam for long-term pharmaceutical needs requires a strategy that ensures supply continuity and regulatory adaptability. The "Shipping Time" is often described as "Fresh Stock, Ready Shipment," which is advantageous for minimizing lead times. However, buyers must verify the actual availability of stock against their production schedules. The "Shipping Method" offers flexibility, including air, sea, express, and special shipping lines. The choice of shipping method will impact the cost, speed, and environmental conditions of the delivery, which is crucial for maintaining the stability of the API.

The "Customization" attribute suggests that suppliers are willing to adapt to specific buyer needs, which can be beneficial for long-term partnerships. However, customization often introduces variability that must be managed through strict quality agreements. Buyers should establish clear specifications for the "prod_model" or product model, such as "A248," "HDM-Piroxicam," or "Frazer-Piroxicam," to ensure consistency across orders. The "Resource" attribute, sometimes listed as "Natural," requires clarification to avoid confusion with the chemical synthesis process. A robust procurement strategy involves regular audits of the supplier's quality management system, verification of their certification status, and continuous monitoring of the product's shelf life and storage conditions to mitigate the risk of degradation.

Comparative Analysis of Product Attributes

To facilitate decision-making, the following table summarizes key attributes observed in the market for Piroxicam, highlighting the variations buyers may encounter.

This comparative view underscores the importance of defining precise requirements before engaging with suppliers. The variability in attributes means that a "one-size-fits-all" approach to sourcing is ineffective. Buyers must tailor their specifications to their specific operational needs, ensuring that the selected Piroxicam meets the rigorous demands of pharmaceutical manufacturing. By focusing on these detailed attributes, procurement teams can mitigate risks and secure a reliable supply chain for this essential pharmaceutical ingredient.